No,구분,개별,평가의뢰일,평가의뢰기관,재평가,평가의뢰종목,법인번호,평가종류,회차,민감도,주기,기준일,평가값송부일,보고서송부일,민감도송부일,평가담당자,공수,전기평가,RM,결과보고서송부,등록월,등록그룹,담당자,연락처,Mail,평가목적,종목등록일
1620,-,기초자산,"아이엠라이프(구,DGB생명보험)(수익증권)펀드(기초자산)",스틱오퍼튜니티제삼호사모투자,재평가,오케스트로,1101116738136 ,A07,1,-,분기 ,2024-09-30,2024-10-10,보고서제공X,-,이상민, - ,이상민,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
4249,메디히어 플립,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,재평가,"Doctorhere, Inc.(구, 메디히어)",KBP2024090070,D06,1,-,분기,2024-09-30,2024-10-07,보고서제공X,-,이상민, 0.4 ,김예림,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
4316,-,기초자산,한국투자증권(기획조정실)펀드(기초자산),한국투자바이오글로벌펀드,재평가,차이코퍼레이션,1101116871960 ,A05,0,-,분기,2024-09-30,평가철회,평가철회,-,이진주, - ,이진주,-,-,평가철회,평가철회,0,0,0,-,0
4437,메디히어 플립,기초자산,"삼성증권(PM팀)(구,전략투자팀)펀드(기초자산)",인터베스트4차산업혁명투자조합2,재평가,"Doctorhere, Inc.(구, 메디히어)",KBP2024090070,D06,0,-,분기 ,2024-09-30,2024-10-07,보고서제공X,-,이상민, - ,이상민,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
4483,-,기초자산,"삼성증권(PM팀)(구,전략투자팀)펀드(기초자산)",스톤브릿지DX사업재편투자조합,재평가,리브스메드,1101114625385 ,A07,2,-,분기 ,2024-09-30,2024-10-07,보고서제공X,-,서동현, - ,서동현,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
5335,-,기초자산,현대해상펀드(기초자산),아주좋은벤처펀드2.0,신규,인벤티지랩,1311110409481 ,D02,2,-,분기 ,2024-09-30,2024-10-04,보고서제공X,-,상장, - ,상장,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,0
5363,-,개별종목,2024-09-26,한국투자증권(PB전략부),신규,비바리퍼블리카,1101115119080 ,A01,0,-,분기,2024-09-30,2024-10-04,2024-10-04,-,이현승, 1.0 ,이현승,신원준,신원준,202409,[Y]금융기관,석재민차장,02-3276-6152,seokjaem@koreainvestment.com,회계반영,9
5364,-,개별종목,2024-09-26,한국투자증권(PB전략부),신규,현대머티리얼,1101114364008 ,A01,0,-,분기,2024-09-30,2024-10-04,2024-10-04,-,신원준, 1.0 ,신규,신원준,신원준,202409,[Y]금융기관,석재민차장,02-3276-6152,seokjaem@koreainvestment.com,회계반영,9
5425,-,개별종목,2024-10-02,KB손해보험(LT),신규,삼성유럽인프라대출일반사모투자신탁제3호,KBP2024090016,B02,0,-,분기,2024-09-30,룩스루,룩스루,-,대체평가3사업본부, - ,대체평가3사업본부,-,-,202409,[T]기타보험기관[1본부],최서희선임,02-2144-7421,seohee.choi@ kblife.co.kr ,-,0
5426,-,개별종목,2024-10-02,"삼성증권(채널솔루션지원팀)(구,영업전략팀)",재평가,두나무,1101114834853 ,A01,0,-,분기 ,2024-09-30,2024-10-07,2024-10-07,-,김수현, 1.0 ,김수현,정재형,정재형,202409,[B]삼성,김정용수석,02-2020-7164,jungyeung.kim@samsung.com,회계반영,0
5427,-,개별종목,2024-10-02,"삼성증권(채널솔루션지원팀)(구,영업전략팀)",재평가,야놀자,1101113612375 ,A01,1,-,분기 ,2024-09-30,2024-10-07,2024-10-07,-,정재형, - ,정재형,정재형,정재형,202409,[B]삼성,김유리수석,02-2020-7136,youri.kim@samsung.com,회계반영,0
5428,-,개별종목,2024-10-02,경보제약,신규,일송켐,1201111153056 ,A01,0,-,미정,2024-09-30,2024-12-23,2025-01-20,-,채동우, 1.0 ,신규,채동우,채동우,202411,[X]일반기업,정재용팀장,02-2175-2310,jjydrama@kbpharma.co.kr,회계반영,1
5429,-,개별종목,2024-10-02,타임폴리오자산운용,신규,넥스트플레이어,1101115161883 ,A01,0,-,미정,2024-06-30,2024-10-21,2024-10-21,-,서경덕, 1.0 ,서경덕,정은채,정은채,202409,[Y]금융기관,이녹형부장,02-533-9985(411),luna@timefolio.co.kr;ai@timefolio.co.kr,매매검토/자전거래,0
5430,-,개별종목,2024-10-02,타임폴리오자산운용,신규,넥스트플레이어,1101115161883 ,A07,5,-,미정,2024-06-30,2024-10-21,2024-10-21,-,서경덕, - ,서경덕,정은채,정은채,202409,[Y]금융기관,이녹형부장,02-533-9985(411),luna@timefolio.co.kr;ai@timefolio.co.kr,매매검토/자전거래,0
5431,-,개별종목,2024-10-02,타임폴리오자산운용,신규,넥스트플레이어,1101115161883 ,A07,7,-,미정,2024-06-30,2024-10-21,2024-10-21,-,서경덕, - ,서경덕,정은채,정은채,202409,[Y]금융기관,이녹형부장,02-533-9985(411),luna@timefolio.co.kr;ai@timefolio.co.kr,매매검토/자전거래,0
5432,-,개별종목,2024-10-02,타임폴리오자산운용,신규,네이처라운드,1346110138938 ,A01,0,-,미정,2024-06-30,2024-10-21,2024-10-21,-,윤광일, 1.0 ,신규,정은채,정은채,202409,[Y]금융기관,이녹형부장,02-533-9985(411),luna@timefolio.co.kr;ai@timefolio.co.kr,매매검토/자전거래,1
5433,-,개별종목,2024-10-02,타임폴리오자산운용,신규,버즈빌,1101114856724 ,A01,0,-,미정,2024-06-30,2024-10-21,2024-10-21,-,김수현, 1.0 ,김수현,정은채,정은채,202409,[Y]금융기관,이녹형부장,02-533-9985(411),luna@timefolio.co.kr;ai@timefolio.co.kr,매매검토/자전거래,0
5434,-,개별종목,2024-10-02,메리츠증권(구조화투자팀),신규,폴라리스쉬핑,1101113047754 ,D06,77,-,분기 ,2024-09-30,2024-10-11,평가보고서X,-,오영석, 1.0 ,조현우,최수민,메자닌평가팀,202409,[Y]금융기관,박지우과장,02-6454-4321,jw.park@meritz.co.kr;youjung.lee@meritz.co.kr,회계반영,2
5435,-,개별종목,2024-10-02,메리츠증권(구조화투자팀),신규,폴라리스쉬핑,1101113047754 ,D06,771,-,분기 ,2024-09-30,2024-10-11,평가보고서X,-,오영석, - ,조현우,최수민,메자닌평가팀,202409,[Y]금융기관,박지우과장,02-6454-4321,jw.park@meritz.co.kr;youjung.lee@meritz.co.kr,회계반영,2
5436,-,개별종목,2024-10-02,메리츠증권(구조화투자팀),신규,폴라리스쉬핑,1101113047754 ,D03,77,-,분기 ,2024-09-30,2024-10-11,평가보고서X,-,오영석, - ,조현우,최수민,메자닌평가팀,202409,[Y]금융기관,박지우과장,02-6454-4321,jw.park@meritz.co.kr;youjung.lee@meritz.co.kr,회계반영,2
5437,-,기초자산,"아이엠라이프(구,DGB생명보험)(수익증권)펀드(기초자산)",스틱오퍼튜니티제삼호사모투자,신규,재원산업,2062110001780 ,D02,0,-,분기 ,2024-09-30,2024-10-10,보고서제공X,-,신원준, - ,신규,-,-,202409,[6]기타기관펀드(기초자산),0,0,0,-,1
5438,-,개별종목,2024-10-02,삼보모터스,재평가,삼보모터스,1101110545529 ,D02,13,-,분기 ,2024-09-30,2024-10-18,2024-10-25,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,홍영국부장,"053-606-7107, 010-5038-7548 ",hongyg@sambomotors.com ,회계반영,0
5439,손상검토,개별종목,2024-10-02,삼성물산(건설부문),재평가,SAMSUNG C&T (KL) SDN BHD(말레이시아법인),KBP2016120199,A01,0,-,연말,2024-10-31,2024-11-29,2024-12-06,-,강승현, 3.0 ,강승현,변혜진,변혜진,202410,[B]삼성,조한재프로,02-2145-5600,h2o.jo@samsung.com,-,0
5440,-,개별종목,2024-10-02,삼성물산(건설부문),재평가,Qurayyah Investment Company,KBP2016120195,D06,1,-,연말,2024-10-31,2024-11-29,2024-12-06,-,변혜진, 1.0 ,변혜진,변혜진,변혜진,202410,[B]삼성,조한재프로,02-2145-5600,h2o.jo@samsung.com,-,0
5441,손상검토,개별종목,2024-10-02,삼성물산(건설부문),재평가,SAMSUNG C&T(SHANGHAI) CO LTD(중국법인),KBP2016120198,A01,0,-,연말,2024-10-31,2024-11-29,2024-12-06,-,강성은, 3.0 ,강성은,변혜진,변혜진,202410,[B]삼성,조한재프로,02-2145-5600,h2o.jo@samsung.com,-,0
5442,-,개별종목,2024-10-02,삼성물산(건설부문),재평가,Qurayyah Investment Company,KBP2016120195,D06,2,-,연말,2024-10-31,2024-11-29,2024-12-06,-,변혜진, - ,변혜진,변혜진,변혜진,202410,[B]삼성,조한재프로,02-2145-5600,h2o.jo@samsung.com,-,0
5443,-,개별종목,2024-10-02,티에스인베스트먼트(상장),재평가,티에스인베스트먼트,1101113840843 ,D02,3,-,반기 ,2024-09-28,2024-10-08,2024-10-18,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202409,[W]상장기업,임혁빈부장,02-6250-5705,imhb@tsinvestment.co.kr,회계반영,0
